U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Itraconazole Oral Suspension
  1. Development Resources

Itraconazole Oral Suspension

FDA identified interpretive criteria:

 

Minimum Inhibitory
Concentrations

(mcg/mL)
Broth Microdilution
at 48 Hours

Disk Diffusion
(zone diameters in mm)

 

Pathogen

S

I

R

S

I

R

Candida albicansa

≤ 0.125

0.25 – 0.5

> 1

-

-

-

S = Susceptible; I = Intermediate; R = Resistant
a Mucosal isolates only

Back to Top